 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 04/18/2024 |
$1.37 |
$1.44 |
$1.33 |
$1.39 |
2.56M | | 04/19/2024 |
$1.35 |
$1.38 |
$1.31 |
$1.36 |
2.96M | | 04/22/2024 |
$1.37 |
$1.40 |
$1.34 |
$1.36 |
2.01M | | 04/23/2024 |
$1.38 |
$1.41 |
$1.35 |
$1.37 |
2.11M | | 04/24/2024 |
$1.37 |
$1.40 |
$1.35 |
$1.37 |
1.51M |
|
|
| Akebia Therapeutics is a biopharmaceutical company. Co.'s portfolio includes a late-stage product candidate and a commercial product: Vadadustat, which is an investigational oral hypoxia-inducible factor prolyl hydroxylase inhibitor designed to mimic the physiologic effect of altitude on oxygen availability; and Auryxia® (ferric citrate), which is approved and marketed in the U.S. for two indications which are the control of serum phosphorus levels in adult patients with chronic kidney disease (CKD) on dialysis or the Hyperphosphatemia Indication, and the treatment of iron deficiency anemia (IDA) in adult patients with CKD not on dialysis or the IDA Indication. | |
|
Akebia Therapeutics (AKBA) has the following price history information. Looking back at AKBA historical stock prices for the last five trading days, on April 18, 2024, AKBA opened at $1.37, traded as high as $1.44 and as low as $1.33, and closed at $1.39. Trading volume was a total of 2.56M shares. On April 19, 2024, AKBA opened at $1.35, traded as high as $1.38 and as low as $1.31, and closed at $1.36. Trading volume was a total of 2.96M shares. On April 22, 2024, AKBA opened at $1.37, traded as high as $1.40 and as low as $1.34, and closed at $1.36. Trading volume was a total of 2.01M shares. On April 23, 2024, AKBA opened at $1.38, traded as high as $1.41 and as low as $1.35, and closed at $1.37. Trading volume was a total of 2.11M shares. On April 24, 2024, AKBA opened at $1.37, traded as high as $1.40 and as low as $1.35, and closed at $1.37. Trading volume was a total of 1.51M shares.
AKBA Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Akebia Therapeutics shares, starting with a $10,000 purchase of AKBA, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
04/28/2014 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$23.00 |
|
| End price/share: |
$1.37 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-94.04% |
|
| Average Annual Total Return: |
-24.58% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$595.94 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 04/18/2024 | $1.39 | | 04/19/2024 | $1.36 | | 04/22/2024 | $1.36 | | 04/23/2024 | $1.37 | | 04/24/2024 | $1.37 |
|
|
Free AKBA Email Alerts:
